Canada Markets close in 4 hrs 46 mins

Investors Eyeing New Trends in Biopharma & Healthcare: Stocks Heading Higher

CORAL GABLES, FL / ACCESSWIRE / November 2, 2018 / The recent boom for things like medical marijuana in the UK as well as the rise of healthcare technology have investors interested in new and exciting companies. The recent surge in interest has seen sector stocks boom. Recent developments across both sectors have new companies targeting expanded market share.

Just this week shares of Premier Health Group (PHGI.CN) (PHGRF) saw its shares begin to trade higher. Technology has become a major part of the healthcare industry, as we know it. The marketplace is no longer solely focused on drug treatments or FDA trials. Access to services is becoming a larger focus for today's ''on the go'' population. The telemedicine approach has begun to open new opportunities for a number of public and private companies alike. Could it also be the future for things like the marijuana industry? Time will tell.

For Premier Health Group (PHGI.CN) (PHGRF) there could be a big crossover between healthcare technology and realized growth from the cannabis market. In it's October corporate update, the company stated its expansion plan. This plan also includes new clinic openings, acquisitions (clinic, technology, and patients) and cannabis clinic(s) and partnerships.

The company has further focused on the developments of telehealth services for a very underserved country, which has also legalized cannabis; Canada. The company's subsidiary, HealthVue has an ecosystem of over 100,000 active patients, and according to the company, they also have plans to ''rapidly increase that number both domestically and internationally.'' Unlike other telehealth companies listed, HealthVue also has 4 clinics in British Columbia with plans to expand to the rest of Canada via its telemedicine model.

The benefit to Premier Health is that it can tap into the existing payment structure that Canada offers. Unlike the US, the telemedicine visits are already covered by the provincial health insurance plans in several provinces so there is no cost to the patient to access this service. HealthVue expects to make the first version of the app available to their patients in Q4-18.

More Information On Premier Health Group, Click Here

In other news, The Greater Cannabis Company, Inc. (OTC PINK: GCAN) has taken a different approach to the ''healthcare/cannabis'' connection. The company is a biopharmaceutical company focused on development and commercialization of innovative delivery systems for the Cannabis market.

The Company recently completed development and reformulation of its eluting patch (EPP) for cannabinoid use. The EPP has been developed in the past for pharmaceutical and over the counter products, as well as for oral health applications.

Further to this, The Greater Cannabis Company has entered into a new stage of ramping up its efforts to commercialize the technology through sublicensing and joint venture agreements. Target partners include licensed producers and dealers in the United States, Canada, and abroad, as well as pharmaceutical companies focused on cannabinoids therapies.

''We are head down and intently focused on bringing our technology to market, and closing deals. The principles of the Company have personally invested hundreds of thousands of dollars into acquiring the rights to technology and developing it for cannabinoid use,'' commented Mr. Zacharin, CEO of Greater Cannabis.

More Information On Greater Cannabis Company Click Here

These are just a few examples of the types of innovation being created with the advent of technology and the boom that the legal cannabis industry has begun to create. In their own respects, each industry (healthcare technology and cannabis) have growth potential ahead. The global medical cannabis market size was estimated to be more than US$ 11 Billion in 2017. The cannabis market value is further expected to reach around US$ 37 Billion by 2023, exhibiting a CAGR of around 22% during 2017-2023 according to a report from Research And Markets. In addition to this, there are a slew of companies applying to list on major US Exchanges including the likes of Aphria (APH.TO) (NYSE:APHA) which was formerly listed on the US OTC exchange under the symbol (APHQF).

Furthermore, the MarketsAndMarkets report "Healthcare IT Market by Product (EHR, RIS, PACS, VNA, CPOE, HIE, Telehealth, Healthcare Analytics, Population Health Management, Supply Chain Management, CRM, Fraud Management, Claims Management) End User (Provider, Payer) - Global Forecast to 2021", shows that the healthcare IT market is projected to reach $280.25 Billion by 2021 from $134.25 Billion in 2016, at a CAGR of 15.9% during the forecast period.

In all cases, the markets have begun to see increased trading activity and share prices during the early stages of growth. For investors, there may be plenty more information to look forward to as these markets evolve.

What Is Stock Price (

Stock Price is defined as the price of a single share of a number of saleable stocks of a public company. A stock price is the highest amount an investor or trader is willing to pay for the stock, or the lowest amount that it can be bought for. was created for everyone that wants the latest stock quotes, stock charts, company news, and the best financial content.

At Stock Price (, you get free stock quotes, up-to-date news, international market data, social interaction and the best financial content that will help you manage your financial life.

Legal Disclaimer

Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. JSG Communications, LLC which owns is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release.

JSG Communications, LLC, which owns, may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice. JSG Communications, LLC, which owns, may be compensated for its services in the form of cash-based compensation or equity securities in the companies it writes about, or a combination of the two. Pursuant to an agreement between MIDAM VENTURES, LLC an affiliate of JSG COMMUNICATIONS LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 – 4/1/2018 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $100,000 (CASH) for & were paid ''500,000'' shares of restricted common shares. We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six month restriction is complete on 4/1/2019 we plan to sell the ''500,000'' shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Please click here for full disclaimer.

Contact Information: